HONG KONG, March 1 /PRNewswire/ - Today, www.WorldStreetFundamentals.com released its industry report highlighting Keryx Biopharmaceuticals (NASDAQ: KERX) and Jazz Pharmaceuticals, Inc. (NASDAQ: JAZZ). Investors from around the world are invited to view fundamental and technical analysis at www.WorldStreetFundamentals.com.
Biotech is enabling creation of new drugs at a faster pace than previous traditional pharmaceutical models. After a decade of mediocre performance the sector appears to be approaching an inflection point. Companies are much more conducive to focusing on productivity and emerging markets are expected to be back to top growth by 2013.
World Street has highlighted Keryx Biopharmaceuticals due to its recent price-movement in its historical $3.50-$4.00 value range. Several major Wall Street firms are reiterating their "buy" ratings in anticipation of potentially successful results in Keryx's two Phase III trials with the FDA, including KRX-0401 (Perifosine) and Zerenex (Ferric Citrate). To read the report on Keryx Biopharmaceuticals (NASDAQ: KERX), visit www.WorldStreetFundamentals.com.
Jazz Pharmaceuticals, Inc. (NASDAQ: JAZZ) continues to perform well into 2011, breaking $20 resistance levels with strong volume. World Street recognizes Jazz Pharmaceuticals for its recently granted patent related to Xyrem (sodium oxybate) oral solution: "Microbiologically Sound and Stable Solutions of Gamma-Hydroxybutyrate Salt for the Treatment of Narcolepsy". The patent, number 7,851,506, became a catalyst for recent price movement and is already listed in the Orange Book (FDA's Approved Drug Products List).
To view fundamental and technical analysis on these two industry members we encourage investors to visit: www.WorldStreetFundamentals.com.
About World Street
World Street Fundamentals is an online portal for professionals, investors and new-comers to the markets to find in depth comprehensive research and research tools to help guide you through the ever changing financial markets around the world. Covering the top performers in the hottest sectors and providing clarity to investors around the world.
FOR INFORMATIONAL PURPOSES ONLY, NO RECOMMENDATION TO BUY OR SELL SECURITIES SHOULD BE CONSTRUED FROM THIS RELEASE. WORLD STREET HAS NO RELATIONSHIP WITH THE ABOVE MENTIONED COMPANIES AND HAS NOT BEEN COMPENSATED BY ANY THIRD-PARTY.
SOURCE World Street Fundamentals